Company STADA Arzneimittel

Equities

SAZ

DE0007251803

Pharmaceuticals

Delayed Xetra 5-day change 1st Jan Change
- EUR -.--% Intraday chart for STADA Arzneimittel -1.95% -8.87%

Business Summary

STADA Arzneimittel AG (STADA) is a global pharmaceutical company that focuses on multisource products. It focuses on three core business segments: Generics offers drugs in the multisource product category, made from readily available, off-patent active ingredients; Brand-Name Products focuses on multisource products that are accessible without active ingredient research and are principally offered to the public in the non-prescription and self-medication product sectors, while Special Pharmaceuticals focuses on products with specific market entry barriers or specialized sales structures, including oncological drugs. STADA generics are sold by numerous subsidiaries in the respective national markets.

Managers

Managers TitleAgeSince
Chief Executive Officer 59 18-08-31
Director of Finance/CFO - 22-12-31
Chief Tech/Sci/R&D Officer 59 14-12-31
Investor Relations Contact - -
General Counsel - -
General Counsel - -
Human Resources Officer 46 18-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 56 17-09-25
Director/Board Member - 17-09-25
Chairman 73 17-09-26
Director/Board Member 67 16-08-25
Director/Board Member 44 14-06-03
Director/Board Member 45 17-09-26
Director/Board Member - 20-12-31
Director/Board Member 53 09-12-31
Director/Board Member 62 18-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 62,342,440 61,635,585 ( 98.87 %) 84,273 ( 0.1352 %) 98.87 %

Company contact information

STADA Arzneimittel AG

Stadastrasse 2-18

61118, Bad Vilbel

+49 6101 603 0

http://www.stada.com
address STADA Arzneimittel(SAZ)

Group companies

NameCategory and Sector
Financial Conglomerates
Eurogenerics NV
Medical Distributors
Pharmaceuticals: Major
  1. Stock Market
  2. Equities
  3. SAZ Stock
  4. Company STADA Arzneimittel